Your browser doesn't support javascript.
loading
The band and slough technique is effective for management of diminutive type 1 gastric and duodenal neuroendocrine tumors.
Hawa, Fadi; Sako, Zeyad; Nguyen, Than; Catanzaro, Andrew T; Zolotarevsky, Eugene; Bartley, Angela N; Gunaratnam, Naresh T.
Afiliação
  • Hawa F; Department of Internal Medicine, St. Joseph Mercy Ann Arbor Hospital, Ypsilanti, Michigan, United States.
  • Sako Z; Department of Hematology and Oncology, Ascension St. John Hospital, Detroit, Michigan, United States.
  • Nguyen T; Department of Gastroenterology and Hepatology, Kaiser Permanente Vacaville Medical Center, Vacaville, California, United States.
  • Catanzaro AT; Department of Gastroenterology and Hepatology, Huron Gastroenterology Associates, St. Joseph Mercy Ann Arbor Hospital, Ypsilanti, Michigan, United States.
  • Zolotarevsky E; Department of Gastroenterology and Hepatology, Spectrum Health Hospitals, Grand Rapids, Michigan, United States.
  • Bartley AN; Department of Pathology, St. Joseph Mercy Ann Arbor Hospital, Ypsilanti, Michigan, United States.
  • Gunaratnam NT; Department of Gastroenterology and Hepatology, Huron Gastroenterology Associates, St. Joseph Mercy Ann Arbor Hospital, Ypsilanti, Michigan, United States.
Endosc Int Open ; 8(6): E717-E721, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32490154
ABSTRACT
Background and study aims Endoscopic resection is recommended as initial treatment for early-stage gastric and duodenal neuroendocrine tumors (G-NETs and D-NETs). However, it can cause serious adverse events. We aimed to evaluate the efficacy and safety of the band and slough (BAS) technique as a novel and less aggressive endoscopic therapy for management of such tumors. Four patients, three diagnosed with < 10-mm D-NET and one with 10-mm type I G-NET, were treated with the BAS technique without endoscopic resection. Initial follow-up endoscopy at 3 months was done to assess for residual tumor. Subsequent endoscopic surveillance was performed. After one session of banding, all patients achieved complete remission at 3-month follow-up. No tumor recurrence was detected on repeat biopsy at 12-month surveillance endoscopy. None of the patients developed any adverse events including bleeding or perforation. The BAS technique may prove to be a safe and effective endoscopic therapy for diminutive, non-metastatic type 1 G-NETs and D-NETs. Studies of larger scale and longer follow-up periods are needed to corroborate these findings.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article